Physician profile
Nicholas Blasingame
NPI 1033792411
$7,720.69
in general payments reported to CMS, 2019-2025
13 companies · $426 in 2025
The $426 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $168 · 2023: $1,753 · 2024: $5,374 · 2025: $426.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $5,688 · Food and Beverage: $1,865.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $5,688.28 |
| Food and Beverage | $1,864.58 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kerecis Limited | $5,038.76 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose |
| Stryker Corporation | $837.66 | 2023-2025 | Ortholoc 3di, Axsos, Allograft |
| Orthofix Medical, INC. | $538.54 | 2023 | Truelok, Galaxy Fixation System |
| Acera Surgical, INC. | $277.15 | 2023 | Restrata Wound Matrix |
| Medline Industries LP | $167.83 | 2022 | |
| Lifenet Health | $158.33 | 2023 | |
| Smith+Nephew, INC. | $142.85 | 2024 | Pico |
| Paratek Pharmaceuticals, INC. | $123.73 | 2023 | Nuzyra |
| Averitas Pharma INC. | $122.13 | 2023 | Qutenza |
| Treace Medical Concepts, INC. | $112.87 | 2024 | |
| Kci USA, INC. | $87.80 | 2023 | Prevena |
| Medinc of Texas | $57.95 | 2023 | |
| Mission Medical Distribution, LLC | $55.09 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicholas Blasingame listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.